BA
Bandhan Focused Fund Direct Growth
Latest NAV
+2.62% 1Y
Sign In to Add to Portfolio
Benchmark: BSE 500 TRI
Expense ratio
1.01%
AUM
₹2,094 Cr
Min SIP
₹100
Min lump sum
₹1,000
1Y
+2.62%
3Y (ann.)
+15.10%
5Y (ann.)
+12.11%
Launched
Jan 2013
Where the NAV sits & how risky it is
₹105.04
52-week range
at 70%
₹105.04
Low 31 Mar 2026₹91.70
High 23 Sep 2026₹110.64
Risk level
Very High
Low
Very high
NAV history
03 Jan 2013
Since inception
01 Oct 2026
Returns by period
1W
-4.53%
1M
-0.57%
3M
-0.15%
6M
+11.69%
1Y
+2.62%
3Y
+15.10%
5Y
+12.11%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 95.19%
Cash & other 5.27%
Sector split
Country split
Top 5 hold 30.2%
Top 10 hold 52.8%
30 equity holdings
Equity holdings
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | LT Foods
INE818H01020 |
Consumer Defensive Packaged Foods |
India |
7.63%
|
-1.78% |
| 2 | HDFC Bank
INE040A01034 |
Financial Services Banks - Regional |
India |
5.96%
|
-20.81% |
| 3 | Power Finance Corporation
INE134E01011 |
Financial Services Credit Services |
India |
5.75%
|
+22.33% |
| 4 | Prestige Estates Projects
INE811K01011 |
Real Estate Real Estate - Diversified |
India |
5.44%
|
-4.62% |
| 5 | Jubilant Pharmova
INE700A01033 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.42%
|
-8.69% |
| 6 | Cholamandalam Financial Holdings
INE149A01033 |
Financial Services Credit Services |
India |
5.27%
|
-12.75% |
| 7 | Glenmark Pharmaceuticals
INE935A01035 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
4.86%
|
+5.97% |
| 8 | State Bank of India
INE062A01020 |
Financial Services Banks - Regional |
India |
4.42%
|
+5.14% |
| 9 | ICICI Bank
INE090A01021 |
Financial Services Banks - Regional |
India |
4.37%
|
-0.64% |
| 10 | Tilaknagar Industries
INE133E01013 |
Consumer Defensive Beverages - Wineries & Distilleries |
India |
3.71%
|
-5.52% |
About this scheme
The investment objective of the Scheme is seek to generate capital appreciation by investing in a concentrated portfolio of equity and equity related instruments up to 30 companies. There is no assurance or guarantee that the objectives of the scheme will be realized.
Fund manager(s): Manish Gunwani, Rahul Aggarwal, Kirthi Jain, Ritika Behera, Gaurav Satra
Exit load: Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
01 Jan 2013
Lump-sum min
₹1,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 118.9 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 30.8 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 28.0 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 28.0 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 26.6 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 26.5 pts ahead of this fund